| Literature DB >> 21691519 |
Brigitte M Baumann1, Christopher J Russo, Daniel Pavlik, Tara Cassidy-Smith, Naomi Brown, Alfred Sacchetti, Lisa M Capano-Wehrle, Rakesh D Mistry.
Abstract
OBJECTIVES: To compare the evaluation and management of pediatric cutaneous abscess patients at three different emergency department (ED) settings.Entities:
Year: 2011 PMID: 21691519 PMCID: PMC3099600
Source DB: PubMed Journal: West J Emerg Med ISSN: 1936-900X
Patient characteristics for academic pediatric, general academic pediatric and community emergency department (ED).
| Female, n, % | 114, 57% | 61, 61% | 55, 60% | 230, 59% |
| Predisposing conditions | ||||
| History of prior abscess | 55, 28% | 34, 34% | 16, 17% | 105, 27% |
| In contact with prior abscess patient | 39, 20% | 26, 26% | 7, 8% | 72, 18% |
| Attend daycare (children <5 years) | 17 of 101, 17% | 4 of 30, 13% | 4 of 35, 11% | 25 of 166, 15% |
| Hospitalized in past 30 days | 13, 7% | 3, 3% | 4, 4% | 20, 5% |
| Most common abscess sites | ||||
| Lower extremity | 50, 25% | 42, 42% | 29, 32% | 121, 31% |
| Buttock | 51, 26% | 21, 21% | 22, 24% | 94, 24% |
| Abdomen | 16, 8% | 17, 17% | 11, 12% | 44, 11% |
| Face | 23, 12% | 6, 6% | 9, 10% | 38, 10% |
| Upper extremity | 22, 11% | 8, 8% | 7, 8% | 37, 9% |
| Axilla | 13, 7% | 9, 9% | 4, 4% | 26, 7% |
| Groin | 14, 7% | 5, 5% | 5, 5% | 24, 6% |
| Multiple abscesses at presentation | 59, 30% | 31, 31% | 7, 8% | 97, 25% |
| Surrounding cellulitis | 168, 84% | 21, 21% | 16, 17% | 205, 52% |
| Presence of fever (≥38° Celsius) | 41, 21% | 11, 11% | 13, 14% | 65, 17% |
| Hospitalized | 48, 24% | 0 | 10, 11% | 58, 15% |
If noted in the medical record that there was an area of cellulitis surrounding the abscess
Temperature measured rectally in children <5 years and orally if ≥5 years.
Medical management and culture results at three pediatric care settings.
| Underwent incision and drainage in ED, n, % | 92, 46% | 74, 74% | 50, 54% | < 0.0001 |
| Infiltrated anesthetic (lidocaine) | 23 of 92, 25% | 22 of 74, 30% | 34 of 50, 68% | < 0.0001 |
| Topical anesthetic cream | 53 of 92, 58% | 53 of 74, 72% | 0 | < 0.0001 |
| Procedural sedation used | 26 of 92, 28% | 24 of 74, 32% | 6 of 50, 12% | 0.04 |
| Packing placed in abscess cavity | 16 of 92, 17% | 39 of 74, 53% | 25 of 50, 50% | < 0.0001 |
| Wound culture obtained | 126 of 156, 81% | 70 of 89, 79% | 18 of 63, 29% | < 0.0001 |
| Organisms obtained at culture | ||||
| MRSA | 74 of 126, 59% | 53 of 70, 76% | 11 of 18, 61% | 0.06 |
| MSSA | 28 of 126, 22% | 17 of 70, 24% | 5 of 18, 28% | 0.85 |
| Other organism(s) | 24 of 126, 19% | 0 | 2 of 18, 11% | 0.0005 |
χ2 used to compare patient management and organism characteristics at the three settings.
Wound culture percentages reflect only those patients who had a spontaneously draining abscess or underwent incision and drainage of their abscess, including in the operating room.
ED, emergency department; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus
Discharge instructions and follow up at three pediatric care settings.
| Adjuvant antibiotics given at discharge, n, % | 148, 97% | 89, 89% | 76, 93% | 0.05 |
| Empiric coverage for MRSA | 140, 92% | 86, 86% | 58, 71% | <0.0001 |
| Trimethoprim-sulfamethoxazole | 34 of 140, 24% | 63 of 86, 73% | 57 of 58, 98% | <0.0001 |
| Clindamycin | 106 of 140, 76% | 23 of 86, 27% | 1 of 58, 2% | <0.0001 |
| Eradication therapy recommended | 14, 9% | 23, 23% | 0 | <0.0001 |
| Advised to return to ED for follow-up | 8, 5% | 34, 34% | 53, 65% | <0.0001 |
| Patients who returned to the ED for follow up wound care/packing change | 20, 13% | 35, 35% | 30, 37% | <0.0001 |
Empiric antibiotic coverage for MRSA included oral trimethoprim/sulfamethoxazole or clindamycin. Antibiotics used that did not have MRSA coverage included: Cephalexin (n=13), Augmentin (n=6), Amoxicillin (n=5), Doxycycline, (n=2), Tetracycline (n=2), and Ciprofloxacin (n=1)
Eradication therapy using mupirocin ointment, hibiclens/chlorhexidine washes or bleach baths
ED, emergency department; MRSA, methicillin-resistant Staphylococcus aureus
Pain assessment and treatment at three pediatric care settings.
| Pain assessed at triage, n, % | 134, 67% | 87, 87% | 67, 73% | 0.001 |
| Mean pain score | 2.1 ±3.4 | 3.8 ±4.1 | 4.8 ± 3.5 | 0.003 |
| Pain relievers given during ED visit | ||||
| Acetaminophen | 13, 7% | 4, 4% | 6, 7% | 0.66 |
| Ibuprofen | 14, 7% | 13, 13% | 22, 24% | <0.0001 |
| Oral narcotic | 16, 8% | 14, 14% | 20, 22% | 0.004 |
| Topical anesthetic | 57 of 92, 62% | 54 of 74, 73% | 0 | <0.0001 |
| Infiltrated anesthetic (lidocaine) | 23 of 92, 25% | 22 of 74, 30% | 34 of 50, 68% | <0.0001 |
| Discharged with any pain medication | 38 of 152, 25% | 64, 64% | 35 of 82, 43% | <0.0001 |
| Discharged with a narcotic pain medication | 7 of 152, 5% | 9, 9% | 19 of 82, 23% | <0.0001 |
Triage pain scale of 1–10 completed for 63 academic pediatric hospital ED patients, 12 general academic ED patients and 28 community ED patients. The remaining scores were either using the Wong Baker Faces scale or a descriptive assessment.
Topical anesthetic use is only reported for patients who underwent an incision and drainage procedure.
Infiltrated anesthetic was only used in incision and drainage patients.
ED, emergency department
Medical management, culture results and pain control in children >2 years at three pediatric care settings.
| Underwent incision and drainage in ED, n, % | 61, 46% | 62, 72% | 45, 59% | 0.001 |
| Infiltrated anesthetic (lidocaine) | 19 of 61, 31% | 20 of 62, 32% | 30 of 45, 67% | 0.0002 |
| Topical anesthetic cream | 37of 61, 61% | 43 of 62, 69% | 0 | < 0.0001 |
| Procedural sedation used | 18 of 61, 30% | 21 of 62, 34% | 5 of 45, 11% | 0.03 |
| Packing placed in abscess cavity | 13 of 61, 21% | 33 of 62, 53% | 22 of 45, 49% | < 0.0001 |
| Wound culture obtained | 74 of 95, 78% | 61 of 74, 82% | 12 of 56, 21% | < 0.0001 |
| Organisms obtained at culture | ||||
| MRSA | 38 of 74, 51% | 42 of 61, 69% | 7 of 12, 58% | 0.12 |
| MSSA | 18 of 74, 24% | 14 of 61, 23% | 4 of 12, 33% | 0.75 |
| Other organism(s) | 18 of 74, 24% | 0 | 1 of 12, 8% | 0.0001 |
| Adjuvant antibiotics given at discharge | 111 of 113, 98% | 76 of 86, 88% | 64 of 70, 91% | 0.02 |
| Empiric coverage for MRSA | 103 of 113, 91% | 73 of 86, 85% | 49 of 70, 70% | 0.0008 |
| Pain assessed at triage | 134, 67% | 87, 87% | 67, 73% | 0.001 |
| Discharged with any pain medication | 28 of 113, 25% | 56 of 86, 65% | 30 of 70, 43% | <0.0001 |
| Discharged with a narcotic pain medication | 7 of 113, 6% | 9 of 86, 11% | 16 of 70, 23% | <0.0001 |
χ2 used to compare patient management and organism characteristics at the three settings.
Wound culture percentages reflect only those patients who had a spontaneously draining abscess or underwent incision and drainage of their abscess, including in the operating room
ED, emergency department; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus